Overview of Brazilian Requirements for Therapeutic Equivalence of Orally Inhaled and Nasal Drug Products
- PMID: 31236849
- DOI: 10.1208/s12249-019-1415-y
Overview of Brazilian Requirements for Therapeutic Equivalence of Orally Inhaled and Nasal Drug Products
Abstract
Brazil has established a framework for provision of generic pharmaceuticals including for orally inhaled and nasal drug products (OINDP) to its populace. This includes the development of guidelines or "resolutions" and normative instructions describing the Brazilian medicines agency's (Anvisa) expectations for demonstrating OINDP therapeutic equivalence. The Anvisa regulatory framework for OINDP therapeutic equivalence, challenges, and comparisons with the US Food and Drug Administration and European Medicines Agency approaches are assessed and discussed.
Keywords: Anvisa; nasal drug products; orally inhaled drug products; therapeutic equivalence.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical